Powering a healthcare data company with strategic planning

We're partnering with Intelligent Medical Objects to develop growth strategies and build out the organization to scale.

The Opportunity

Intelligent Medical Objects (IMO) is a healthcare data enablement company and market leader in clinical terminology software. Its technology enables doctors and nurses to input diagnoses into electronic health records systems using their own medical lexicon, without needing to manually map that terminology against thousands of codes specific to major healthcare reimbursement systems. As a result, IMO’s software helps hospitals, healthcare systems and physician practices reduce costs and improve billing accuracy. With mission-critical technology enabling providers to deliver better care, IMO had an opportunity at the start of our partnership to accelerate its growth.

The Challenge

IMO’s core platform already fulfilled a critical need for providers by enhancing clinician operational efficiency while improving the accuracy of medical records and billing & coding.  However, the company wanted to expand its reach into new markets via innovative product offerings and strategic M&A.

The Results

Our partnership with IMO focuses on achieving scale through new product capabilities, organic growth initiatives, M&A and investments in its go-to-market function.

Expansion planning

Together with company management, we completed long-term strategic planning by developing a prioritization framework for product development and implementing an M&A strategy.

A robust sales team

We helped conduct key personnel searches to execute against our Value Creation Plan, including a buildout of the sales organization.

Related content

<strong>Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc.</strong>
Press Release
Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc. 

Acquisition to expand IMO’s suite of products to improve patient care, clinical workflows, and healthcare data quality CHICAGO–(BUSINESS WIRE)–Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced today that it has acquired Melax Technologies, Inc. (Melax Tech). Melax Tech empowers the healthcare and life sciences industries through use of Artificial
Thomas H. Lee Partners Acquires Intelligent Medical Objects
Press Release
Thomas H. Lee Partners Acquires Intelligent Medical Objects 

 Investment will support expanded product development and go-to-market activities ROSEMONT, Ill. & BOSTON–(BUSINESS WIRE)–Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in growth companies, announced today that it has entered into an agreement to acquire a majority interest in Intelligent Medical Objects (“IMO,” or “the Company”), a healthcare data enablement company and market

For a list of all portfolio company investments made by THL since its inception, please click here.

Want to know more?

Learn more about our integrated approach to private equity

How we invest